Our executive function is performed by the All.Can Steering Committee which oversees our strategic direction and enforces budgetary control. The Steering Committee includes representatives of All.Can constituencies (patient advocacy, health professionals, research, providers, industry etc.) and election to the Steering Committee is via majority vote by all All.Can members. See our Terms of Reference for more information.
Our current Steering Committee members are listed below:
|Name||Position||Stakeholder group represented||Working group|
|Matti Aapro||Clinique de Genolier, and board member of ECCO and ESO||Healthcare professional||Communications, events and stakeholder engagement|
|Tit Albreht||Slovenian Public Health Institute and iPAAC Joint Action on Cancer Control||Research and healthcare professional||Research and evidence|
|Kathy Barnard||Save Your Skin Foundation Canada||Patient advocacy||National initiatives|
|Alex Filicevas||European Cancer Patient Coalition (ECPC)||Patient advocacy||National initiatives|
|Vivek Muthu||Marivek Healthcare consulting||Research||Research and evidence|
|Kathy Oliver||The International Brain Tumour Alliance (IBTA)||Patient advocacy||Research and evidence and Communications, events and stakeholder engagement|
|Titta Rosvall-Puplett||Bristol-Myers Squibb||Industry||Communications, events and stakeholder engagement|
|Karin Steinmann||Amgen||Industry||Research and evidence|
Both the Steering Committee and members are supported by a secretariat, which performs the operational function of All.Can.